MNMD Stock Forecast: MindMed tumbles in a rocky start to the week of trading

NASDAQ:MNMD fell by 20.99% during Tuesday’s trading session.
MindMed might have a bright future but there is risk involved.
More pain for meme stocks as AMC, GME, and BBBY extend their slide.

Stocks Reporter FXStreet

NASDAQ:MNMD hit a brick wall on Tuesday as the psychedelic biotech company saw its stock price fall off a cliff coming out of the Labor Day long weekend. Shares of MNMD tumbled by 20.99% and closed the trading session at a price of $9.07. This would make its pre-split adjusted price at just $0.60 per share. Stocks extended their declines as all three major indices closed the day in the red. Stronger than expected ISM data from August weighed on investors ahead of the September FOMC meeting on interest rates. Overall, the Dow Jones fell by 173 basis points, the S&P 500 slipped by 0.41%, and the NASDAQ dropped by 0.74% during the session.

Stay up to speed with hot stocks' news!

The reverse stock split certainly leaves a bad taste in the mouths of investors. Just ask those that are invested in cannabis company Sundia (NASDAQ:SNDL). But MindMed does have some promising catalysts including five projects which are in Phase 2 of their clinical trials which means there are plenty of potential treatments coming down the pipeline. It also has a decent cash balance which can allow it to continue with these trials without making much in terms of revenues.

MNMD stock price

MindMed wasn’t the only meme stock declining on Tuesday. Shares of AMC (NYSE:AMC) were down by 7.77%, GameStop (NYSE:GME) by 8.11%, and Bed Bath and Beyond (NASDAQ:BBBY) a further 18.42%. It’s been an ugly couple of weeks for meme stocks following the BBBY short squeeze, and it doesn’t seem like there is any relief on the horizon for meme stock traders.

Like this article? Help us with some feedback by answering this survey:

Premium

You have reached your limit of 3 free articles for this month.

Start your subscription and get access to all our original articles.

Subscribe to Premium Sign In

Author

Stocks Reporter

FXStreet

EUR/USD looks sidelined below 1.1600

EUR/USD remains on the back foot in the latter part of the NA session on Thursday, now attempting a consolidative theme in the sub-1.1600 region. A more cautious market mood, driven by the escalating conflict in the Middle East, together with broad-based strength in the US Dollar, is favouring the continuation of the leg lower in spot.

GBP/USD stays offered near 1.3340

GBP/USD fades Wednesday’s uptick and trades with decent losses in the 1.3340 zone in the latter part of Thursday’s session. Cable’s weakness, alongside the rest of the risk complex, follows the strong performance of the Greenback amid intense geopolitical jitters.

Gold: further weakness could challenge $5,000

Gold comes under fresh selling pressure on Thursday, slipping back below the $5,100 mark per troy ounce. Persistent strength in the US Dollar (USD) is preventing the yellow metal from building a meaningful recovery, even as markets remain risk-averse amid the deepening conflict in the Middle East.

Crypto Today: Bitcoin, Ethereum, XRP hold weekly gains despite US-Iran war

The cryptocurrency market is gaining strength on Thursday, building on Wednesday's upswing, which saw Bitcoin reach a weekly high above $74,000. Ethereum and Ripple are moderating their recent gains amid uncertainty stemming from the escalating war in the Middle East.

Two PMIs, two Chinas

China’s economic data are often treated with a degree of caution by global investors. The challenge is not necessarily that the numbers are incorrect, but that they can describe very different parts of a vast and complex economy. Nowhere is that more evident than in China’s PMIs.

Ripple tests recovery strength amid steady ETF inflows, growing retail interest

Ripple (XRP) continues to demonstrate notable resilience as the cryptocurrency market navigates the persistent war in the Middle East after the United States (US) and Israel attacked Iran on Saturday.